Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 46 of the 56 sources its claims cite were checked for support.
Abstract
Abstract Aging is associated with cell senescence and is the major risk factor for AD. We characterized premature cell senescence in postmortem brains from non-diseased controls (NDC) and donors with Alzheimer’s disease (AD) using imaging mass cytometry (IMC) and single nuclear RNA (snRNA) sequencing (> 200,000 nuclei). We found increases in numbers of glia immunostaining for galactosidase beta (> fourfold) and p16 INK4A (up to twofold) with AD relative to NDC. Increased glial expression of genes related to senescence was associated with greater β-amyloid load. Prematurely senescent microglia downregulated phagocytic pathways suggesting reduced capacity for β-amyloid clearance. Gene set enrichment and pseudo-time trajectories described extensive DNA double-strand breaks (DSBs), mitochondrial dysfunction and ER stress associated with increased β-amyloid leading to premature senescence in microglia. We replicated these observations with independent AD snRNA-seq datasets. Our results describe a burden of senescent glia with AD that is sufficiently high to contribute to disease progression. These findings support the hypothesis that microglia are a primary target for senolytic treatments in AD.
Overview
CoChat Summary
## TL;DR
The study used imaging mass cytometry and snRNA-seq on postmortem human cortex to characterize premature cell senescence in Alzheimer’s disease, finding the strongest senescence signature in microglia. The senescence burden tracked with β-amyloid pathology, with microglia showing reduced phagocytic pathways and evidence for DNA damage, mitochondrial dysfunction, and ER stress.
## Key findings
- In cohort 1 IMC (10 AD vs 10 NDC, middle temporal gyrus), AD tissue had 4.1-fold more GLB1+ microglia, 4.6-fold more GLB1+ oligodendrocytes, and 4-fold more GLB1+ astrocytes than NDC; p16+ microglia increased 1.6-fold in AD.
- In the snRNA-seq dataset, 203,970 nuclei from seven major brain cell types were analyzed; only microglia showed a significant increase in the canonical senescence pathway (CSP) in AD relative to NDC (Wilcoxon p = 0.0087).
- Microglial senescence was linked to β-amyloid: more than 25% of microglia within 10 μm of plaques expressed GLB1, versus 3% of microglia >10 μm from plaques.
- In AD, microglia upregulated DNA damage response and senescence-related genes, while phagocytosis-related pathways were downregulated; the paper also reports replication in independent snRNA-seq datasets and a meta-analysis across 14 datasets, with CSP upregulated in microglia in 12/14 datasets (p = 7e-04).
## Methods
- Postmortem cortical tissue from NDC and AD donors was studied with IMC and snRNA-seq. Cohort 1: 10 NDC and 10 AD donors from MTG; Cohort 2: 8 NDC and 9 AD donors, with 49 brain samples across EC, MTG, and SSC.
- snRNA-seq data were QC-filtered, integrated with LIGER, clustered, and annotated using EWCE against a human brain reference; senescence signatures were assessed with differential expression, gene set enrichment, pseudo-time, and mixed-model regression against β-amyloid.
- IMC was analyzed by co-localization and automated image pipelines; senescent nuclei proportions were compared with Wilcoxon rank-sum tests, and transcriptomic associations used MAST mixed models and gene set analyses.
## Limitations
- The paper states that it measures markers associated with senescence rather than direct evidence of permanent growth arrest.
- Because the study is cross-sectional, the authors say dynamic senescence processes may be biased, likely toward underestimating senescent cell burden.
- The authors note limited age range in the donor population and that the three sampled regions per brain are not fully independent, which limits confidence in some single-gene findings.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 The microglial transcriptome is enriched for senescence gene expression in AD. a Study design showing the three regions from each of the 17 brains from which nuclei were isolated to generate snRNAseq data. b UMAP of seven distinct cell type populations characterized from snRNAseq data generated from 49 brain blocks. c Dot plot showing average scaled expression of genes and percentage of cells expressed from the ‘canonical senescence pathway (CSP)’, the ‘senescence initiating pathway (SIP)’ [16] and a custom senescence set (Supplementary data S5) for each cell type. d Normalised aggregated expression of genes as in (c) projected on UMAP. Color gradient scale showing aggregated gene set score in each nuclei. e Box plot showing scaled mean expression of the CSP genes in each cell type (Wilcoxon rank-sum test). f Percentage of senescent nuclei between AD and NDC across all cell types stratified by brain regions (Wilcoxon rank-sum test, *p ≤ 0.05) (Astro, astrocytes; Micro, microglia; Oligo, oligodendrocytes; OPC, Oligodendrocyte progenitor cells; Vasc, vascular cells; Exc, excitatory neurons, Inh; inhibitory neurons)](https://figures.cochat.ai/paper-figures/bf7e8cb61f7f448986c7f9bf49882e14/characterisation-of-premature-cell-senescence-in-alzheimer-s-disease-using-figure-2.jpg)


![Fig. 5 Sub-populations of microglia differentially express senescence gene signatures. a UMAP dimensionality reduction plot showing microglial sub-populations b Odds-ratio estimates of microglial sub-populations associated with AD (circle; OR estimate obtained from MASC [22], bars; 95% CI). c Differences in relative numbers of each of the microglial sub-populations isolated from AD and NDC cortical brain tissue. d Percentages of microglial sub-populations as a function of β-amyloid (4G8+) load (Micro2 Pearson’s R = 0.63, p value = 1.4e−06). e Boxplot showing normalised mean expression of the CSP gene set in the different microglial sub-populations (Wilcoxon rank-sum test). f Bar plots comparing the proportions of senescent nuclei between AD and Control for Micro1-3 (Wilcoxon test, **p value<0.01). g Correlations of the proportions of Micro1-3 senescent nuclei with β-amyloid (4G8+) immunostained areas in sampled region of each brain (Micro1 Pearson’s R = 0.34, p value = 0.021). h Boxplots showing the scaled mean expression of CSP gene set across microglial sub-population grouped by TREM2 genotype (CV, common allele, or the R47H AD risk variant)](https://figures.cochat.ai/paper-figures/2577778b615c4f4f8eb4baa5b304fe47/characterisation-of-premature-cell-senescence-in-alzheimer-s-disease-using-figure-5.jpg)

![Fig. 7 Premature senescence of microglia with greater pseudo-time in AD is associated with gene signatures for inflammatory activation. a UMAP plot colored by microglial pseudo-time trajectory calculated by Monocle3 [71]. b Heatmap showing the relative enrichment of gene co-expression modules differentially expressed with increasing pseudo-time. Module names are colored according to pseudotime progression: Purple, early-; lilac, mid-; yellow, late-pseudotime c Significantly enriched pathway of the co-expression module genes. Pathway names are colored according to plot (b). d Network plot showing hub genes for each module (distinguished by colours) with senescence pathway associated genes highlighted (black circle)](https://figures.cochat.ai/paper-figures/c7cdba1022f3449cbcebb7bb7dcbf63a/characterisation-of-premature-cell-senescence-in-alzheimer-s-disease-using-figure-7.jpg)
Verification
Claims the paper makes
29 Valid · 2 Not valid · 4 Not checked · 103 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Microglia, oligodendrocytes and astrocytes transcriptomes all showed enrichment for genes upregulated in an early senescence (“senescence initiators”) pathway, but only microglia showed full expression of the full canonical senescence pathway (CSP) [16].”
§ Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics > Discussion Although recent evidence has identified premature cell senescence in AD brains [59], we are not aware of a comprehensive characterization of which cell types are most affected, their relative numbers or the mechanisms responsible [5, 25, 35]. Here, we have used a combination of snRNA sequencing and imaging mass cytometry to characterize cell senescence in AD, describing cell types affected, the association between senescence and AD pathology and providing transcriptomic evidence for mechanisms of senescence. Our results demonstrate that there is a substantial burden of senescent cells in brain cortical grey matter with AD and that cell senescence signatures are most prevalent in microglia and associated with inflammatory activation and downregulation of genes related to β-amyloid phagocytosis. We also provide evidence that microglial senescence in AD is related to β-amyloid by showing greater proportions of senescent microglia near β-amyloid plaques and with greater β-amyloid load, particularly in the sub-population of microglia most enriched for homeostatic markers (Micro1) and DAM-associated genes (Micro2). Additional supportive evidence of β-amyloid induced senescence have come from demonstration of the TREM2 genotype dependence of the senescence signature (see also recent preclinical evidence presented in pre-print [56]). An intriguing aspect of our results is the observed lack of senescence in carriers of the TREM2-R47H variant. Contrary to expectations, this absence of senescence does not confer protective effects, as senescence may not be the predominant phenotype in microglia carrying R47H mutations. Instead, our data suggest that the overall pathology burden associated with R47H, particularly in the context of reduced microglial activation, may overshadow any potential neurotoxic effects attributed to senescent microglia. Our data additionally suggest mechanisms that DNA damage, mitochondrial dysfunction and ER stress associated with inflammatory activation together confer vulnerability to premature senescence in microglia with AD. These associations are supported by pseudo-time analysis that demonstrates the relationships of expression of these pathways with senescence along the inferred progression of microglia towards the alternative end states of apoptosis or senescence, expression of which may be related to the severity and chronicity of the stressors responsible [59]. Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80]. Most have focused on single or small numbers of markers of senescence, which likely accounts for some differences in conclusions that have been drawn. We employed multiplexed immunohistology and transcriptomics analyses of postmortem human brains to assess senescence more comprehensively. This highlighted the complexity of profiling senescence-related cell phenotypes. For example, we found increased levels of GLB1 protein expression [19, 75] in microglia, oligodendrocytes and astrocytes. However, as GLB1 expression alone cannot distinguish between senescent cells and cells with intrinsically high lysosomal content and is less associated to senescence in post-mitotic cells such as neurons, we also employed p16 and p21 as markers of an arrested cell cycle and γH2AX to detect DNA double-strand breaks (DSBs) [41, 52]. We found microglia to be the only cell type with significant increase in all markers in AD. Microglia, oligodendrocytes and astrocytes transcriptomes all showed enrichment for genes upregulated in an early senescence (“senescence initiators”) pathway, but only microglia showed full expression of the full canonical senescence pathway (CSP) [16]. By this criterion, only microglia showed strong evidence for premature senescence with AD. Our data suggest mitochondrial dysfunction and ER stress are common mechanisms driving the premature microglial senescence in AD, but does not directly implicate impaired autophagy, as suggested by a recent preclinical study [69]. However, this deserves further investigation as it may reflect limitations of the range of cell processes, we were able to interrogate. Also mitochondrial dysfunction can lead to ER stress through impaired autophagy [4]. While we identified Olig2+ cells expressing some senescence markers, joint use of transcriptomic data was able to more probably ascribe this senescence signature predominantly to oligodendrocytes rather than OPC, which had been implicated in an earlier preclinical study [80]. Oligodendroglial cells also increased expression of ER and related cell stress pathway transcriptomes with increasing β-amyloid load. We found only a smaller, more partial senescence response associated with DSB identified by γH2AX and DNA damage associated pathway expression in inhibitory neurons specifically. Dehkordi et al. previously concluded that excitatory neurons uniquely expressed a senescence signature based on relative enrichment of nuclear genes expressed with an eigengene reflecting a canonical senescence response [16]. Our different conclusion likely reflects the lower specificity of the eigengene approach relative to the simultaneous application of the multiple approaches here, but also could be influenced by differences between the brains sampled in two studies, differences in pathological features correlated (early β-amyloid pathology here vs later phospho-Tau pathology in the earlier paper) and relative weights of the marker gene expressed (i.e., use of CDKN2D in excitatory neurons [16]). In line with this, we found an apparent difference in senescence cell burden between allocortex (EC) and neocortex (MTG, SSC). The strengths of our study were that we applied both immunohistological and transcriptomic analyses to identify cells expressing senescence markers with AD and that we included analyses of regions showing different levels of AD pathology in each brain. However, like all previous studies of AD, our analyses described markers associated with senescence rather than providing direct evidence of permanent growth arrest for the potentially replicating glia. Processes leading to senescence also evolve dynamically, as our results showing varying degrees of partial senescence phenotypes with pseudo-time imply. Describing a dynamic process using a cross-sectional sampling strategy can lead to strong biases in inferences particularly regarding the proportion of end stage events. This could introduce bias particularly towards underestimates of the senescent cell burden. Cell senescence also is related to aging, as we showed for the non-diseased control brains. Our analysis of the contribution of aging to senescence in AD (either directly or through interactions) was limited by the low range of ages in the donor population. As aging is the strongest risk factor for AD, this deserves further study. Finally, the power to detect differentially expressed genes with AD or β-amyloid depends strongly on numbers of independent samples [62]. While 49 different brain blocks were characterized for our study, the three regions studied from each brain are not fully independent. This limits confidence particularly for single gene identifications. We mitigated this by replication of key observations with independent datasets, by highlighting results in agreement with prior studies that this work was extending and by analyses of gene sets, for which power should be substantially higher. Nonetheless, more work needs to be done to more confidently define specific genes whose expression appears to drive the pathology. Preclinical studies using different models have suggested that senolytic treatments can reduce the abundance of senescent cells, disease-relevant pathology and cognitive deficits [8, 56, 80]. The extent to which cell senescence could contribute either to susceptibility to or the progression of human AD is important to answer fully in assessing the therapeutic potential of senolytics for this indication. Our study describes extensive cell stress associated with premature senescence in microglia in established AD. It additionally highlights that, by reducing phagocytic gene signatures in microglia in association with the induction of premature senescence, β-amyloid could reduce its own clearance and potentiate disease progression. Based on our observations, we hypothesise that microglia should be a primary focus for senolytic treatments in AD. They might be used synergistically with other strategies to enhance clearance of β-amyloid pathology [11]. This therapeutic opportunity provides a rationale for further characterization of mechanisms responsible for premature senescence in microglia.
What the sources say
- Disputedcites [16] Dehkordi SK, Walker J, Sah E, Bennett E, Atrian F, Frost B et al (2021) Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology. Nat Aging 1:1107–1116. https://doi.org/10.1038/s43587-021-00142-3 sourceExperimental — accuracy not yet measured
The paper’s results (section labeled Abstract; page unavailable) say excitatory neurons were the predominant CSP-positive cells, accounting for 97% and 92% of CSP cells in the two adult brain cohorts. They also report CSP enrichment in endothelial cells in cohort 2. This contradicts the claim that only microglia showed the canonical senescence phenotype. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Transcripts for senescence associated genes including YPEL3, which encodes a protein downstream of p53 in the senescence pathway induced by DNA damage [36], IQGAP2, IL15, AXL, PIK3R1, CDK6, PECAM1 and CXCL16 were significantly upregulated in microglia with increasing β-amyloid load (Fig. 4c, d) [61].”
§ Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics > Results > Premature senescence in microglia with AD is associated with increased β-amyloid
What the sources say
- Supportedcites [36] Kelley KD, Miller KR, Todd A, Kelley AR, Tuttle R, Berberich SJ (2010) YPEL3, a p53-regulated gene that induces cellular senescence. Cancer Res 70:3566–3575. https://doi.org/10.1158/0008-5472.CAN-09-3219 source
Citation [36] is attached to the description of YPEL3, not to the microglial upregulation finding, which cites [61]. The Abstract identifies YPEL3 as a p53-regulated gene induced by DNA damage and reports that it activates cellular senescence downstream of p53. Page numbers were not supplied. (LLM, conf=0.92)
- Partly supportedcites [61] Saul D, Kosinsky RL, Atkinson EJ, Doolittle ML, Zhang X, LeBrasseur NK et al (2022) A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun 13:4827. https://doi.org/10.1038/S41467-022-32552-1 sourceExperimental — accuracy not yet measured
The Results section ('SenMayo is applicable across tissues and species'; page unavailable) reports enrichment of senescence/SASP genes in aged mouse microglia, and the paper identifies a senescence-associated gene set. It does not report that the eight named transcripts were significantly upregulated in microglia with increasing β-amyloid load; its microglial comparison is by age, not amyloid load. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Aβ1–42 can induce senescence in astrocytes in vitro and greater numbers of p16-positive astrocytes have been reported in the frontal cortex of AD patients compared to that from non-diseased control brains [3].”
§ Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics > Introduction
What the sources say
- Supportedcites [3] Bhat R, Crowe EP, Bitto A, Moh M, Katsetos CD, Garcia FU et al (2012) Astrocyte senescence as a component of Alzheimer’s disease. PLoS ONE 7:e45069–e45069. https://doi.org/10.1371/journal.pone.0045069 source
The Results section reports that synthetic oligomerized Aβ1–42 induced senescence markers in cultured human astrocytes. The paper also reports more p16INK4a-positive astrocytes in the frontal cortex of AD patients than in non-AD adult controls, supporting the rest of the cited sentence. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Additional supportive evidence of β-amyloid induced senescence have come from demonstration of the TREM2 genotype dependence of the senescence signature (see also recent preclinical evidence presented in pre-print [56]).”
§ Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics > Discussion Although recent evidence has identified premature cell senescence in AD brains [59], we are not aware of a comprehensive characterization of which cell types are most affected, their relative numbers or the mechanisms responsible [5, 25, 35]. Here, we have used a combination of snRNA sequencing and imaging mass cytometry to characterize cell senescence in AD, describing cell types affected, the association between senescence and AD pathology and providing transcriptomic evidence for mechanisms of senescence. Our results demonstrate that there is a substantial burden of senescent cells in brain cortical grey matter with AD and that cell senescence signatures are most prevalent in microglia and associated with inflammatory activation and downregulation of genes related to β-amyloid phagocytosis. We also provide evidence that microglial senescence in AD is related to β-amyloid by showing greater proportions of senescent microglia near β-amyloid plaques and with greater β-amyloid load, particularly in the sub-population of microglia most enriched for homeostatic markers (Micro1) and DAM-associated genes (Micro2). Additional supportive evidence of β-amyloid induced senescence have come from demonstration of the TREM2 genotype dependence of the senescence signature (see also recent preclinical evidence presented in pre-print [56]). An intriguing aspect of our results is the observed lack of senescence in carriers of the TREM2-R47H variant. Contrary to expectations, this absence of senescence does not confer protective effects, as senescence may not be the predominant phenotype in microglia carrying R47H mutations. Instead, our data suggest that the overall pathology burden associated with R47H, particularly in the context of reduced microglial activation, may overshadow any potential neurotoxic effects attributed to senescent microglia. Our data additionally suggest mechanisms that DNA damage, mitochondrial dysfunction and ER stress associated with inflammatory activation together confer vulnerability to premature senescence in microglia with AD. These associations are supported by pseudo-time analysis that demonstrates the relationships of expression of these pathways with senescence along the inferred progression of microglia towards the alternative end states of apoptosis or senescence, expression of which may be related to the severity and chronicity of the stressors responsible [59]. Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80]. Most have focused on single or small numbers of markers of senescence, which likely accounts for some differences in conclusions that have been drawn. We employed multiplexed immunohistology and transcriptomics analyses of postmortem human brains to assess senescence more comprehensively. This highlighted the complexity of profiling senescence-related cell phenotypes. For example, we found increased levels of GLB1 protein expression [19, 75] in microglia, oligodendrocytes and astrocytes. However, as GLB1 expression alone cannot distinguish between senescent cells and cells with intrinsically high lysosomal content and is less associated to senescence in post-mitotic cells such as neurons, we also employed p16 and p21 as markers of an arrested cell cycle and γH2AX to detect DNA double-strand breaks (DSBs) [41, 52]. We found microglia to be the only cell type with significant increase in all markers in AD. Microglia, oligodendrocytes and astrocytes transcriptomes all showed enrichment for genes upregulated in an early senescence (“senescence initiators”) pathway, but only microglia showed full expression of the full canonical senescence pathway (CSP) [16]. By this criterion, only microglia showed strong evidence for premature senescence with AD. Our data suggest mitochondrial dysfunction and ER stress are common mechanisms driving the premature microglial senescence in AD, but does not directly implicate impaired autophagy, as suggested by a recent preclinical study [69]. However, this deserves further investigation as it may reflect limitations of the range of cell processes, we were able to interrogate. Also mitochondrial dysfunction can lead to ER stress through impaired autophagy [4]. While we identified Olig2+ cells expressing some senescence markers, joint use of transcriptomic data was able to more probably ascribe this senescence signature predominantly to oligodendrocytes rather than OPC, which had been implicated in an earlier preclinical study [80]. Oligodendroglial cells also increased expression of ER and related cell stress pathway transcriptomes with increasing β-amyloid load. We found only a smaller, more partial senescence response associated with DSB identified by γH2AX and DNA damage associated pathway expression in inhibitory neurons specifically. Dehkordi et al. previously concluded that excitatory neurons uniquely expressed a senescence signature based on relative enrichment of nuclear genes expressed with an eigengene reflecting a canonical senescence response [16]. Our different conclusion likely reflects the lower specificity of the eigengene approach relative to the simultaneous application of the multiple approaches here, but also could be influenced by differences between the brains sampled in two studies, differences in pathological features correlated (early β-amyloid pathology here vs later phospho-Tau pathology in the earlier paper) and relative weights of the marker gene expressed (i.e., use of CDKN2D in excitatory neurons [16]). In line with this, we found an apparent difference in senescence cell burden between allocortex (EC) and neocortex (MTG, SSC). The strengths of our study were that we applied both immunohistological and transcriptomic analyses to identify cells expressing senescence markers with AD and that we included analyses of regions showing different levels of AD pathology in each brain. However, like all previous studies of AD, our analyses described markers associated with senescence rather than providing direct evidence of permanent growth arrest for the potentially replicating glia. Processes leading to senescence also evolve dynamically, as our results showing varying degrees of partial senescence phenotypes with pseudo-time imply. Describing a dynamic process using a cross-sectional sampling strategy can lead to strong biases in inferences particularly regarding the proportion of end stage events. This could introduce bias particularly towards underestimates of the senescent cell burden. Cell senescence also is related to aging, as we showed for the non-diseased control brains. Our analysis of the contribution of aging to senescence in AD (either directly or through interactions) was limited by the low range of ages in the donor population. As aging is the strongest risk factor for AD, this deserves further study. Finally, the power to detect differentially expressed genes with AD or β-amyloid depends strongly on numbers of independent samples [62]. While 49 different brain blocks were characterized for our study, the three regions studied from each brain are not fully independent. This limits confidence particularly for single gene identifications. We mitigated this by replication of key observations with independent datasets, by highlighting results in agreement with prior studies that this work was extending and by analyses of gene sets, for which power should be substantially higher. Nonetheless, more work needs to be done to more confidently define specific genes whose expression appears to drive the pathology. Preclinical studies using different models have suggested that senolytic treatments can reduce the abundance of senescent cells, disease-relevant pathology and cognitive deficits [8, 56, 80]. The extent to which cell senescence could contribute either to susceptibility to or the progression of human AD is important to answer fully in assessing the therapeutic potential of senolytics for this indication. Our study describes extensive cell stress associated with premature senescence in microglia in established AD. It additionally highlights that, by reducing phagocytic gene signatures in microglia in association with the induction of premature senescence, β-amyloid could reduce its own clearance and potentiate disease progression. Based on our observations, we hypothesise that microglia should be a primary focus for senolytic treatments in AD. They might be used synergistically with other strategies to enhance clearance of β-amyloid pathology [11]. This therapeutic opportunity provides a rationale for further characterization of mechanisms responsible for premature senescence in microglia.
What the sources say
- Supportedcites [56] Rachmian N, Medina S, Cherqui U, Akiva H, Deitch D, Edilbi D et al (2023) TREM2-dependent senescent microglia conserved in aging and Alzheimer’s disease. bioRxiv. https://doi.org/10.1101/2023.03.20.533401 source
In “Senescent microglia are TREM2 dependent,” the paper reports significantly fewer senescent microglia in TREM2-knockout 5xFAD mice than in TREM2-intact 5xFAD mice. “The transcript of senescent microglia” also reports that a cluster identified by its senescence signature appeared in 5xFAD mice but was almost entirely absent in the other genotype groups. This supports genotype dependence in the studied mouse models. (LLM, conf=0.90)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We found that SERPINE1, a known senescence marker and SASP factor, was co-expressed with these genes in Module-5 [73].”
§ Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics > Results > Mechanisms of microglial activation by β-amyloid promote premature senescence
What the sources say
- Supportedcites [73] Vaughan DE, Rai R, Khan SS, Eren M, Ghosh AK (2017) Plasminogen activator inhibitor-1 is a marker and a mediator of senescence. Arterioscler Thromb Vasc Biol 37:1446–1452. https://doi.org/10.1161/ATVBAHA.117.309451 source
The Background (page not provided) identifies PAI-1 as a member of the senescence-associated secretory phenotype, and the Abstract and Background describe it as a marker of cellular senescence. The citation supports that characterization of SERPINE1/PAI-1; the Module-5 co-expression is presented as the citing authors’ own finding, not as a finding from this source. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
76 more claims · 5 with their cited sources checked
Create a free account to see all 138 claims and to verify the 2 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 38
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, associations of premature senescence with microglia have been observed in the APP/PS1 mouse model and in postmortem AD samples (Hu et al., 2021;Fancy et al., 2024).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Fancy et al., 2024
In the citing paper
“Indeed, it has been proposed that microglia should be a primary focus for senolytic treatments in AD (Fancy et al., 2024).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Fancy et al., 2024
Citations
Cites
Fast, sensitive and accurate integration of single-cell data with Harmony
Korsunsky, I., Millard, N., Fan, J., Slowikowski, K., Zhang, F., Wei, K., Baglaenko, Y., Brenner, M., Loh, P.-R., & Raychaudhuri, S. (2019) · Nature Methods · doi:10.1038/s41592-019-0619-0 · Cited by 10,488 · cited 1×
“Individual samples were re-integrated using Harmony [39], using Seurat’s RunHarmony() function (group.by.vars = "manifest").”
MethodUMAP: Uniform Manifold Approximation and Projection
McInnes, L., Healy, J., Saul, N., & Großberger, L. (2018) · Journal of Open Source Software · doi:10.21105/joss.00861 · Cited by 9,826 · cited 2×
“…were identified using the DoubletFinder algorithm, with a doublets-per-thousand-cells increment of 8 cells (recommended by 10X Genomics), a pK value of 0.005, and embeddings were generated using the first ten principal components calculated from the top 2000 most highly variable genes (HVGs) [50].”
MethodInfluentialThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“Cell senescence characterized by an irreversible state of cell cycle arrest after proliferative cells reach the so-called “Hayflick limit” is known as replicative senescence [28].”
BackgroundEnrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814 · cited 1×
“Impacted pathway analysis (IPA) was performed essentially as previously described using the enrichR packages in scFlow [12, 44].”
MethodA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Trapnell, C., Cacchiarelli, D., Grimsby, J., Pokharel, P., Li, S., Morse, M., Lennon, N. J., Livak, K. J., Mikkelsen, T. S., & Rinn, J. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2859 · Cited by 7,314 · cited 1×
“The top five marker genes for each automatically annotated cell-type were determined using Monocle 3 and validated against canonical cell-type markers [71].”
MethodLecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678
From Louvain to Leiden: guaranteeing well-connected communities
Traag, V. A., Waltman, L., & van Eck, N. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41695-z · Cited by 5,635
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Expression of a senescence-associated secretory phenotype (SASP) with senescence in either context can initiate inflammatory responses and propagate locally with release of paracrine mediators [14].”
BackgroundNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“It is characterized neuropathologically by extracellular deposits of β-amyloid and intracellular neurofibrillary tangles accompanied by microgliosis, astrogliosis, markers of pan-cellular mitochondrial and lysosomal dysfunction and neurodegeneration [63, 74, 76].”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“However, premature senescence also is observed with chronic stressors in both proliferative and post-mitotic cells in association with chronic oxidative stress or mitochondrial dysfunction and the induction of Page 2 of 21 DNA damage [5, 25, 35, 59].”
BackgroundFinak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., Slichter, C. K., Miller, H. W., McElrath, M. J., Prlic, M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0844-5 · Cited by 3,159 · cited 1×
“…model-based analysis of single-cell transcrip-tomics (MAST) to identify genes differentially expressed (associated) between AD and NDC and with histopathological features (using 4G8 amyloid), using each feature as a dependent variable in a zero-inflated regression analysis using a mixed-model [20].”
MethodWebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144 · cited 1×
“Impacted pathway analysis (IPA) was performed essentially as previously described using the enrichR packages in scFlow [12, 44].”
MethodThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 2×
“Increased numbers of p16-positive astrocytes and microglia also have been reported with tau-mediated disease initiation and progression in a mouse model [8].”
BackgroundSingle-Cell Multi-omic Integration Compares and Contrasts Features of Brain Cell Identity
Welch, J. D., Kozareva, V., Ferreira, A., Vanderburg, C., Martin, C., & Macosko, E. Z. (2019) · Cell · doi:10.1016/j.cell.2019.05.006 · Cited by 1,193 · cited 1×
“The linked inference of genomic experimental relationships (LIGER) package was used to calculate integrative factors across samples [77].”
MethodOligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system
Marques, S., Zeisel, A., Codeluppi, S., van Bruggen, D., Mendanha Falcão, A., Xiao, L., Li, H., Häring, M., Hochgerner, H., Romanov, R. A., et al. (2016) · Science · doi:10.1126/science.aaf6463 · Cited by 1,132 · cited 1×
“We compared the transcriptomics profile of our oligodendrocyte sub-populations with those from the previous studies [33, 48].”
ResultJamboree, P. I. T. 1. H. C. A., Lun, A. T. L., Riesenfeld, S., Andrews, T., Dao, T. P., Gomes, T., & Marioni, J. C. (2019) · Genome Biology · doi:10.1186/s13059-019-1662-y · Cited by 1,097 · cited 1×
“Ambient RNA profiling was performed using emptyDrops with a lower parameter of 100 counts, an alpha cutoff of ≤ 0.001, and with 10,000 Monte-Carlo iterations [45].”
MethodInfluentialA new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
Saul, D., Kosinsky, R. L., Atkinson, E. J., Doolittle, M. L., Zhang, X., LeBrasseur, N. K., Pignolo, R. J., Robbins, P. D., Niedernhofer, L. J., Ikeno, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32552-1 · Cited by 1,022 · cited 1×
“4c, d) [61].”
Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977 · cited 4×
“Preclinical studies using different models have suggested that senolytic treatments can reduce the abundance of senescent cells, disease-relevant pathology and cognitive deficits [8, 56, 80].”
BackgroundInfluentialSala Frigerio, C., Wolfs, L., Fattorelli, N., Thrupp, N., Voytyuk, I., Schmidt, I., Mancuso, R., Chen, W.-T., Woodbury, M. E., Srivastava, G., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.099 · Cited by 926
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915 · cited 1×
“Senescence and apoptosis both can be triggered by aging and chronic cell stress [13, 24].”
BackgroundAltered human oligodendrocyte heterogeneity in multiple sclerosis
Jäkel, S., Agirre, E., Mendanha Falcão, A., van Bruggen, D., Lee, K. W., Knuesel, I., Malhotra, D., ffrench-Constant, C., Williams, A., & Castelo-Branco, G. (2019) · Nature · doi:10.1038/s41586-019-0903-2 · Cited by 854 · cited 3×
“We compared the transcriptomics profile of our oligodendrocyte sub-populations with those from the previous studies [33, 48].”
BackgroundMethodResultThe simple difference formula: An approach to teaching nonparametric correlation
Kerby, D. S. (2014) · Comprehensive Psychology · doi:10.2466/11.it.3.1 · Cited by 806 · cited 1×
“A Wilcoxon rank-sum test was performed to compare the differences of senescent nuclei proportion between AD and NDC across all clusters stratified by brain region and the effect sizes was calculated by the rank-biserial correlation [37].”
MethodvariancePartition: interpreting drivers of variation in complex gene expression studies
Hoffman, G. E., & Schadt, E. E. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1323-z · Cited by 769 · cited 1×
“We then used the dream function from variancePartition package in R [31] to compare the expression changes across the categorical variables or regressed against β-amyloid densities.”
MethodTREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763 · cited 1×
“…in AD depends specifically on microglial activation with β-amyloid, we generated snRNA transcriptomes of microglia obtained from neuro-pathologically defined AD donors carrying the TREM2 R47H variant allele, which is associated with reduced responsiveness of microglia to β-amyloid [68, 83].”
MethodCoupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain
Askew, K., Li, K., Olmos-Alonso, A., Garcia-Moreno, F., Liang, Y., Richardson, P., Tipton, T., Chapman, M. A., Riecken, K., Beccari, S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.041 · Cited by 726 · cited 2×
“This finding is in agreement with an earlier report in which the authors calculated microglial cell-cycle length and concluded that human microglia reach the Hayflick limit for replicative senescence by the age of ~ 80 years [1].”
BackgroundResultA novel cyclin associates with M015/CDK7 to form the CDK-activating kinase
Fisher, R. P., & Morgan, D. O. (1994) · Cell · doi:10.1016/0092-8674(94)90535-5 · Cited by 655 · cited 1×
“Genes for negative regulators of senescence such as GRB2 and NIBAN1 were downregulated with increasing β-amyloid [17, 21, 34, 55].”
BackgroundA guide to assessing cellular senescence in vitro and in vivo
González‐Gualda, E., Baker, A. G., Fruk, L., & Muñoz‐Espín, D. (2021) · The FEBS Journal · doi:10.1111/febs.15570 · Cited by 645 · cited 1×
“Senescence and apoptosis both can be triggered by aging and chronic cell stress [13, 24].”
BackgroundJurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
Tau protein aggregation is associated with cellular senescence in the brain
Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595 · cited 2×
“…cannot distinguish between senescent cells and cells with intrinsically high lysosomal content and is less associated to senescence in post-mitotic cells such as neurons, we also employed p16 and p21 as markers of an arrested cell cycle and γH2AX to detect DNA double-strand breaks (DSBs) [41, 52].”
BackgroundAstrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 2×
“Aβ 1–42 can induce senescence in astrocytes in vitro and greater numbers of p16-positive astrocytes have been reported in the frontal cortex of AD patients compared to that from non-diseased control brains [3].”
BackgroundButterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526 · cited 1×
“We hypothesized that the activation of senescence pathways in AD could be triggered by chronic oxidative stress from interactions with β-amyloid species [9].”
BackgroundBlazek, D., Kohoutek, J., Bartholomeeusen, K., Johansen, E., Hulinkova, P., Luo, Z., Cimermancic, P., Ule, J., & Peterlin, B. M. (2011) · Genes & Development · doi:10.1101/gad.16962311 · Cited by 522 · cited 1×
“Micro3 showed similarities to HM_3, HM_4 phenotype but also expressed APOE , apoptosis associated genes XAF1, YWHAB, YWHAG, YWHAE encoding 14–3-3 protein subunits, cell-cycle and cell division control genes CDK12, MIS18BP1, TAF1D, BOD1L1 and CCAR1 [6, 30, 67].”
BackgroundA transcriptomic atlas of aged human microglia
Olah, M., Patrick, E., Villani, A.-C., Xu, J., White, C. C., Ryan, K. J., Piehowski, P., Kapasi, A., Nejad, P., Cimpean, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02926-5 · Cited by 482 · cited 1×
“Ageing is the greatest risk factor for AD [26, 53, 60] and is associated with cellular senescence.”
BackgroundMarkers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466 · cited 1×
“We included an antibody for p21 CIP1 (p21, encoded by CDKN1A ), that functions to maintain the viability of DNA damage ‐ induced senescent cells and one for γ-H2AX, a marker of DNA double-strand breaks (DSBs) [2, 79].”
BackgroundUsing single nuclei for RNA-seq to capture the transcriptome of postmortem neurons
Krishnaswami, S. R., Grindberg, R. V., Novotny, M., Venepally, P., Lacar, B., Bhutani, K., Linker, S. B., Pham, S., Erwin, J. A., Miller, J. A., et al. (2016) · Nature Protocols · doi:10.1038/nprot.2016.015 · Cited by 445 · cited 1×
“Nuclei were isolated as previously described [66] using a protocol based on [40] .”
MethodThe age factor in Alzheimer’s disease
Guerreiro, R., & Bras, J. (2015) · Genome Medicine · doi:10.1186/s13073-015-0232-5 · Cited by 415 · cited 1×
“Ageing is the greatest risk factor for AD [26, 53, 60] and is associated with cellular senescence.”
BackgroundSadick, J. S., O’Dea, M. R., Hasel, P., Dykstra, T., Faustin, A., & Liddelow, S. A. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.008 · Cited by 415
Biczo, G., Vegh, E. T., Shalbueva, N., Mareninova, O. A., Elperin, J., Lotshaw, E., Gretler, S., Lugea, A., Malla, S. R., Dawson, D., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.10.012 · Cited by 406 · cited 1×
“Also mitochondrial dysfunction can lead to ER stress through impaired autophagy [4].”
BackgroundControl of mitochondrial permeability by Bcl-2 family members
Sharpe, J. C., Arnoult, D., & Youle, R. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.016 · Cited by 367 · cited 1×
“Interestingly, “regulation of mitochondrial membrane depolarization”, which included LRRK2 and BCL2 genes, both of which can regulate apoptotic cell death pathways, was upregulated with increased β-amyloid [64].”
BackgroundSkene, N. G., & Grant, S. G. N. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00016 · Cited by 349 · cited 1×
“Automated cell-typing was performed essentially as previously described using the Expression Weighted Celltype Enrichment (EWCE) algorithm in scFlow against a previously generated cell-type data reference from the Allan Human Brain Atlas [38, 65].”
MethodHu, Y., Fryatt, G. L., Ghorbani, M., Obst, J., Menassa, D. A., Martin-Estebane, M., Muntslag, T. A. O., Olmos-Alonso, A., Guerrero-Carrasco, M., Thomas, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109228 · Cited by 298
Self-citationYosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V. (2017) · The EMBO Journal · doi:10.15252/embj.201695553 · Cited by 293 · cited 1×
“We included an antibody for p21 CIP1 (p21, encoded by CDKN1A ), that functions to maintain the viability of DNA damage ‐ induced senescent cells and one for γ-H2AX, a marker of DNA double-strand breaks (DSBs) [2, 79].”
BackgroundPlasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence
Vaughan, D. E., Rai, R., Khan, S. S., Eren, M., & Ghosh, A. K. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.309451 · Cited by 258 · cited 1×
“We found that SERPINE1, a known senescence marker and SASP factor, was co-expressed with these genes in Module-5 [73].”
BackgroundCellular senescence and Alzheimer disease: the egg and the chicken scenario
Saez-Atienzar, S., & Masliah, E. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0325-z · Cited by 257
Immunosenescence of microglia and macrophages: impact on the ageing central nervous system
Rawji, K. S., Mishra, M. K., Michaels, N. J., Rivest, S., Stys, P. K., & Yong, V. W. (2016) · Brain · doi:10.1093/brain/awv395 · Cited by 252 · cited 1×
“3c), consistent with previous reports describing reduced phagocytic capacity of senescent microglia with ageing [57].”
BackgroundCellular senescence at the crossroads of inflammation and Alzheimer's disease
Guerrero, A., De Strooper, B., & Arancibia-Cárcamo, I. L. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.06.007 · Cited by 236 · cited 1×
“Accumulation of senescent cells in aging tissues can be accelerated by a wide range of cell stressors, including chronic inflammation [27].”
BackgroundOsorio, D., & Cai, J. J. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa751 · Cited by 212
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Smith, A. M., Davey, K., Tsartsalis, S., Khozoie, C., Fancy, N., Tang, S. S., Liaptsi, E., Weinert, M., McGarry, A., Muirhead, R. C. J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02372-6 · Cited by 209
Self-citationEarly Alzheimer’s disease pathology in human cortex involves transient cell states
Gazestani, V., Kamath, T., Nadaf, N. M., Dougalis, A., Burris, S. J., Rooney, B., Junkkari, A., Vanderburg, C., Pelkonen, A., Gomez-Budia, M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.005 · Cited by 209 · cited 2×
“9a–c) [23].”
MethodHerdy, J. R., Traxler, L., Agarwal, R. K., Karbacher, L., Schlachetzki, J. C. M., Boehnke, L., Zangwill, D., Galasko, D., Glass, C. K., Mertens, J., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.010 · Cited by 208
BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks
Higgs, M. R., Reynolds, J. J., Winczura, A., Blackford, A. N., Borel, V., Miller, E. S., Zlatanou, A., Nieminuszczy, J., Ryan, E. L., Davies, N. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.007 · Cited by 194 · cited 1×
“Micro3 showed similarities to HM_3, HM_4 phenotype but also expressed APOE , apoptosis associated genes XAF1, YWHAB, YWHAG, YWHAE encoding 14–3-3 protein subunits, cell-cycle and cell division control genes CDK12, MIS18BP1, TAF1D, BOD1L1 and CCAR1 [6, 30, 67].”
BackgroundRachmian, N., Medina, S., Cherqui, U., Akiva, H., Deitch, D., Edilbi, D., Croese, T., Salame, T. M., Ramos, J. M. P., Cahalon, L., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01620-8 · Cited by 180
Fonseka, C. Y., Rao, D. A., Teslovich, N. C., Korsunsky, I., Hannes, S. K., Slowikowski, K., Gurish, M. F., Donlin, L. T., Lederer, J. A., Weinblatt, M. E., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq0305 · Cited by 177
Profiling senescent cells in human brains reveals neurons with CDKN2D/p19 and tau neuropathology
Dehkordi, S. K., Walker, J., Sah, E., Bennett, E., Atrian, F., Frost, B., Woost, B., Bennett, R. E., Orr, T. C., Zhou, Y., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00142-3 · Cited by 169 · cited 10×
“Microglia, oligodendrocytes and astrocytes transcriptomes all showed enrichment for genes upregulated in an early senescence (“senescence initiators”) pathway, but only microglia showed full expression of the full canonical senescence pathway (CSP) [16].”
BackgroundMethodResultInfluentialA multi-pronged human microglia response to Alzheimer’s disease Aβ pathology
Mancuso, R., Fattorelli, N., Martinez-Muriana, A., Davis, E., Wolfs, L., Van Den Daele, J., Geric, I., Preman, P., Serneels, L., Poovathingal, S., et al. (2022) · doi:10.1101/2022.07.07.499139 · Cited by 169
Sudom, A., Talreja, S., Danao, J., Bragg, E., Kegel, R., Min, X., Richardson, J., Zhang, Z., Sharkov, N., Marcora, E., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002352 · Cited by 149 · cited 1×
“…in AD depends specifically on microglial activation with β-amyloid, we generated snRNA transcriptomes of microglia obtained from neuro-pathologically defined AD donors carrying the TREM2 R47H variant allele, which is associated with reduced responsiveness of microglia to β-amyloid [68, 83].”
MethodBielak-Zmijewska, A., Wnuk, M., Przybylska, D., Grabowska, W., Lewinska, A., Alster, O., Korwek, Z., Cmoch, A., Myszka, A., Pikula, S., et al. (2014) · Biogerontology · doi:10.1007/s10522-013-9477-9 · Cited by 139 · cited 2×
“However, premature senescence also is observed with chronic stressors in both proliferative and post-mitotic cells in association with chronic oxidative stress or mitochondrial dysfunction and the induction of Page 2 of 21 DNA damage [5, 25, 35, 59].”
BackgroundDileep, V., Boix, C. A., Mathys, H., Marco, A., Welch, G. M., Meharena, H. S., Loon, A., Jeloka, R., Peng, Z., Bennett, D. A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.038 · Cited by 130 · cited 1×
“However, features of premature senescence associated particularly with DNA double-strand breaks (DSBs) and p16 expression also have been described in post-mitotic cells such as neurons[16, 18, 29].”
BackgroundOxidation resistance 1 is a novel senolytic target
Zhang, X., Zhang, S., Liu, X., Wang, Y., Chang, J., Zhang, X., Mackintosh, S. G., Tackett, A. J., He, Y., Lv, D., et al. (2018) · Aging Cell · doi:10.1111/acel.12780 · Cited by 127 · cited 1×
“The Micro3 subpopulation increased TAOK1 expression, the protein product of which is involved in mitotic G2 DNA damage checkpoint signalling and the expression of genes for the positive regulators of senescence OXR1 (Oxidation Resistance 1) and PELI1 [46, 81] (Supplementary data S12).”
BackgroundThe Absolute Number of Oligodendrocytes in the Adult Mouse Brain
Valério-Gomes, B., Guimarães, D. M., Szczupak, D., & Lent, R. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00090 · Cited by 123 · cited 1×
“…V–VI, Supplementary data S1) to assess the co-localization of cell type specific protein markers (microglia, Iba1; oligodendrocyte lineage, OLIG2 [72]; astrocyte, GFAP; endothelial cell, GLUT1; neuron, MAP2) with GLB1, which encodes β-galactosidase, a marker for senescence-associated increases…”
BackgroundPaglinawan, R., Malipiero, U., Schlapbach, R., Frei, K., Reith, W., & Fontana, A. (2003) · Glia · doi:10.1002/glia.10286 · Cited by 122 · cited 1×
“Genes for negative regulators of senescence such as GRB2 and NIBAN1 were downregulated with increasing β-amyloid [17, 21, 34, 55].”
BackgroundZhao, J., Zhang, L., Lu, A., Han, Y., Colangelo, D., Bukata, C., Scibetta, A., Yousefzadeh, M. J., Li, X., Gurkar, A. U., et al. (2020) · Aging · doi:10.18632/aging.102863 · Cited by 122 · cited 1×
“ZFP36L2, ZFP36L1 are associated with SASP and ATM is known to be the key driver of DNA-damage induced senescence [82].”
BackgroundKey Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation
Caldeira, C., Cunha, C., Vaz, A. R., Falcão, A. S., Barateiro, A., Seixas, E., Fernandes, A., & Brites, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00277 · Cited by 117 · cited 1×
“We then explored biological pathways whose expression was enriched with increased β-amyloid load and these glial signatures of premature senescence or its initiation [10, 15].”
BackgroundscPower accelerates and optimizes the design of multi-sample single cell transcriptomic studies
Schmid, K. T., Höllbacher, B., Cruceanu, C., Böttcher, A., Lickert, H., Binder, E. B., Theis, F. J., & Heinig, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26779-7 · Cited by 108
Venkataraman, A. V., Mansur, A., Rizzo, G., Bishop, C., Lewis, Y., Kocagoncu, E., Lingford-Hughes, A., Huiban, M., Passchier, J., Rowe, J. B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk1051 · Cited by 101
Self-citationMatsudaira, T., Nakano, S., Konishi, Y., Kawamoto, S., Uemura, K., Kondo, T., Sakurai, K., Ozawa, T., Hikida, T., Komine, O., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05027-2 · Cited by 98
Wagner, J., Damaschke, N., Yang, B., Truong, M., Guenther, C., McCormick, J., Huang, W., & Jarrard, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124366 · Cited by 83 · cited 1×
“For example, we found increased levels of GLB1 protein expression [19, 75] in microglia, oligodendrocytes and astrocytes.”
BackgroundMirzayans, R., Andrais, B., Hansen, G., & Murray, D. (2012) · Biochemistry Research International · doi:10.1155/2012/951574 · Cited by 81
Levine, J., Kwon, E., Paez, P., Yan, W., Czerwieniec, G., Loo, J. A., Sofroniew, M. V., & Wanner, I. (2016) · Glia · doi:10.1002/glia.22953 · Cited by 76 · cited 1×
“…the pathways expressed varied between cells, e.g., upregulated genes in oligodendrocytes were associated with interleukin-1-mediated signaling pathway, while those in astrocytes were associated with more general reactive and migratory astrocytic responses (e.g., ACTN4, EGFR, SASH1 ) [43, 78].”
BackgroundYPEL3, a p53-Regulated Gene that Induces Cellular Senescence
Kelley, K. D., Miller, K. R., Todd, A., Kelley, A. R., Tuttle, R., & Berberich, S. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3219 · Cited by 73 · cited 1×
“Transcripts for senescence associated genes including YPEL3, which encodes a protein downstream of p53 in the senescence pathway induced by DNA damage [36], IQGAP2, IL15, AXL, PIK3R1, CDK6, PECAM1 and CXCL16 were significantly upregulated in microglia with increasing β-amyloid load (Fig.”
BackgroundJiang, W., Wei, K., Pan, C., Li, H., Cao, J., Han, X., Tang, Y., Zhu, S., Yuan, W., He, Y., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12502 · Cited by 67
Molecular basis for Cdk1‐regulated timing of Mis18 complex assembly and CENP‐A deposition
Spiller, F., Medina‐Pritchard, B., Abad, M. A., Wear, M. A., Molina, O., Earnshaw, W. C., & Jeyaprakash, A. A. (2017) · The EMBO Reports · doi:10.15252/embr.201643564 · Cited by 66 · cited 1×
“Micro3 showed similarities to HM_3, HM_4 phenotype but also expressed APOE , apoptosis associated genes XAF1, YWHAB, YWHAG, YWHAE encoding 14–3-3 protein subunits, cell-cycle and cell division control genes CDK12, MIS18BP1, TAF1D, BOD1L1 and CCAR1 [6, 30, 67].”
BackgroundMitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
Weidling, I., & Swerdlow, R. H. (2019) · Biology · doi:10.3390/biology8020039 · Cited by 58 · cited 1×
“It is characterized neuropathologically by extracellular deposits of β-amyloid and intracellular neurofibrillary tangles accompanied by microgliosis, astrogliosis, markers of pan-cellular mitochondrial and lysosomal dysfunction and neurodegeneration [63, 74, 76].”
BackgroundBortolomeazzi, M., Montorsi, L., Temelkovski, D., Keddar, M. R., Acha‐Sagredo, A., Pitcher, M. J., Basso, G., Laghi, L., Rodriguez‐Justo, M., Spencer, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28470-x · Cited by 46
Suelves, N., Saleki, S., Ibrahim, T., Palomares, D., Moonen, S., Koper, M. J., Vrancx, C., Vadukul, D. M., Papadopoulos, N., Viceconte, N., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01578-x · Cited by 43 · cited 1×
“Our data suggest mitochondrial dysfunction and ER stress are common mechanisms driving the premature microglial senescence in AD, but does not directly implicate impaired autophagy, as suggested by a recent preclinical study [69].”
Stress-induced (Premature) senescence
Debacq-Chainiaux, F., Ben Ameur, R., Bauwens, E., Dumortier, E., Toutfaire, M., & Toussaint, O. (2016) · Healthy Ageing and Longevity · doi:10.1007/978-3-319-26239-0_13 · Cited by 31 · cited 1×
“We then explored biological pathways whose expression was enriched with increased β-amyloid load and these glial signatures of premature senescence or its initiation [10, 15].”
BackgroundNIBAN1, Exploring its Roles in Cell Survival Under Stress Context
Diana, P., & Carvalheira, G. M. G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.867003 · Cited by 26 · cited 1×
“Genes for negative regulators of senescence such as GRB2 and NIBAN1 were downregulated with increasing β-amyloid [17, 21, 34, 55].”
BackgroundHMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion
Wu, R., Yan, Y., Ma, C., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1645-7 · Cited by 24
scFlow: A Scalable and Reproducible Analysis Pipeline for Single-Cell RNA Sequencing Data
Khozoie, C., Fancy, N., Marjaneh, M. M., Murphy, A. E., Matthews, P. M., & Skene, N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.16.456499 · Cited by 21 · cited 2×
“Downstream primary analyses of gene-cell matrices were performed using our scFlow pipeline [38].”
MethodSelf-citationMa, J., Zhang, Y.-T., Wang, L., Sun, Q., Zhang, H., Li, J.-J., Han, N., Zhu, Y., Xie, X., & Li, X. (2022) · Cells · doi:10.3390/cells11193115 · Cited by 14 · cited 1×
“The Micro3 subpopulation increased TAOK1 expression, the protein product of which is involved in mitotic G2 DNA damage checkpoint signalling and the expression of genes for the positive regulators of senescence OXR1 (Oxidation Resistance 1) and PELI1 [46, 81] (Supplementary data S12).”
BackgroundWidespread cell stress and mitochondrial dysfunction in early Alzheimer’s DiseasePreprint
Venkataraman, A. V., Mansur, A., Rizzo, G., et al. (2021) · medRxiv · doi:10.1101/2021.08.11.21261851 · Cited by 7 · cited 1×
“It is characterized neuropathologically by extracellular deposits of β-amyloid and intracellular neurofibrillary tangles accompanied by microgliosis, astrogliosis, markers of pan-cellular mitochondrial and lysosomal dysfunction and neurodegeneration [63, 74, 76].”
BackgroundTREM2-dependent senescent microglia conserved in aging and Alzheimer’s disease
Rachmian, N., Medina, S., Cherqui, U., Akiva, H., Deitch, D., Edilbi, D., Croese, T., Salame, T., Peralta Ramos, J., Cahalon, L., et al. (2023) · doi:10.1101/2023.03.20.533401 · Cited by 6
Cited by
Inflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 164
“Moreover, characterization post-mortem AD brain tissue revealed senescent microglia associated with inflammatory activation and downregulated phagocytic capacity [65].”
The Role of Glial Cell Senescence in Alzheimer's Disease
Alshaebi, F., Sciortino, A., & Kayed, R. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70051 · Cited by 60
“…cortical tissue from ad patients showed significantly higher numbers of senescent microglia, characterized by increased expression of p16 INK4A , p21 WAF1/CIP1 , γH2AX, and GLB1 (encoding for β-galactosidase), when compared to age-matched non-demented control individuals (Fancy et al. 2024).”
InfluentialMitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 63
Navigating oligodendrocyte precursor cell aging in brain health
Leenders, F., Koole, L., Slaets, H., Tiane, A., van den Hove, D., & Vanmierlo, T. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111959 · Cited by 35
Hudson, H. R., Sun, X., & Orr, M. E. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00519 · Cited by 33
Metadata
- Authors
- Fancy, N. N., Smith, A. M., Caramello, A., Tsartsalis, S., Davey, K., Muirhead, R. C. J., McGarry, A., Jenkyns, M. H., Schneegans, E., Chau, V., Thomas, M., Boulger, S., Cheung, T. K. D., Adair, E., Papageorgopoulou, M., Willumsen, N., Khozoie, C., Gomez-Nicola, D., Jackson, J. S., & Matthews, P. M.
- Affiliations
- Hammersmith Hospital (GB)
- University of Auckland (NZ)
- University of Geneva (CH)
- King's College London (GB)
- Corresponding author
- Matthews, Paul M.
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2024-05-02
- Volume
- 147
- Issue
- 1
- Pages
- 78-78
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC11065703
- OpenAlex
- W4396591445
- Cited by
- 48
- References
- 85
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 10
- FWCI
- 13.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- UK Dementia Research Institute
- Medical Research Council
- Alzheimer’s Research UK
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- Alzheimer's disease, microglia, amyloid-beta, DNA double-strand breaks, mitochondrial dysfunction, endoplasmic reticulum stress, phagocytosis, p16INK4a, senolytics, aging, postmortem brain
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Female, Humans, Male, Neuroglia, Amyloid beta-Peptides, Cellular Senescence, Microglia, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.